Yes. This is a compounded oral prescription medication requiring a valid prescription from a licensed healthcare provider. A telehealth consultation and hair loss evaluation are required before dispensing to confirm diagnosis, assess pattern and severity, screen for contraindications, and establish the appropriate dosing protocol.

Oral finasteride may cause reduced libido, erectile dysfunction, or ejaculatory changes in a small percentage of men. Report any sexual side effects to your provider promptly. Oral minoxidil at low doses can cause fluid retention, mild ankle swelling, or reflex tachycardia, particularly during the first few weeks. An initial shedding phase during the first 4 to 8 weeks is common — this reflects follicular transition and resolves as treatment continues. Women of childbearing potential must not use or handle this medication due to finasteride's teratogenic risk.

Women who are pregnant or may become pregnant must not use or handle this product. Men with a history of prostate cancer, breast cancer, or hypersensitivity to finasteride or minoxidil should not use this formulation without oncological evaluation. Patients with significant cardiovascular conditions, including heart failure or arrhythmia, require individualized assessment before using oral minoxidil. Hepatic impairment may affect finasteride metabolism and requires provider evaluation.

Finasteride is metabolized by CYP3A4, strong inhibitors or inducers may alter finasteride plasma levels. Minoxidil may have additive blood pressure-lowering effects when combined with antihypertensive medications, particularly relevant if meaningful systemic absorption occurs. Patients on anticoagulants, cardiovascular medications, or any agents that affect hepatic enzyme activity should disclose these to their provider before beginning treatment.

Patients with cardiovascular disease, hepatic conditions, or a history of hormone-sensitive malignancy require careful individualized assessment. Oral minoxidil is not appropriate for patients with significant cardiac conditions without specialist clearance. Your provider will review your complete health history before prescribing and establish a monitoring plan appropriate to your baseline health.